首页|Receptor based virtual screening of potential novel inhibitors of tigar [TP53 (tumour protein 53)-induced glycolysis and apoptosis regulator
Receptor based virtual screening of potential novel inhibitors of tigar [TP53 (tumour protein 53)-induced glycolysis and apoptosis regulator
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
TP53 (tumor protein 53)-induced glycolysis and apoptosis regulator (TIGAR) belongs to the phosphatases family of proteins that modulates the level of reactive oxygen species in tumor cells。 This protein plays a vital role as a negative regulator of glycolysis， thus lowering ROS levels in the cells， which helps the cancerous cells to resist programmed cell death。 Besides， TIGAR also mediates the DNA damage repair in cancer cells by increasing tumor cell survival。 In the current study， we have screened natural products that compete with the substrate to bind to the active site of TIGAR。 Extra precision and MMGBSA scoring function were used to screen the lead molecules。 Five compounds were considered as lead molecules with 2-(2-(3，4-dihydroxy phenyl)-3，5-dihydroxy-8-(4-hydroxyphenyl)-4-oxo-4H-furo[2，3-h]chromen-9-yl) acetic acid(DDFA) as a top lead with a docking score of -9。428， and -53。16 MMGBSA， bind to the positively charged amino acids present in the active site。 Further， the molecular dynamics simulation studies indicated the structural stability attained by TIGAR protein upon the binding of DDFA， suggesting it to be a potent inhibitor of TIGAR， and could be employed as an anticancer drug during combinational therapy。
NSTL
